Tomonaga M
Dept. of Hematology, Nagasaki University School of Medicine.
Gan To Kagaku Ryoho. 2000 Jul;27(8):1133-8.
The JALSG was founded in 1987 as the first large scale multi-center study group for adult leukemia in Japan. It has grown up to be an internationally-recognized national group consisting of 66 institutions. Each protocol for AML has recruited more than 300 new cases for the study period of two years, enabling randomized studies. JALSG's studies have been published in international journals and contributed much to evidence-based medicine in Japan. For administrative purposes, an Internet system has been employed with a great success for case entry and data management. Governmental research funding for cancer research has been provided to the chief doctor of JALSG, enhancing its research activity greatly. Future JALSG studies will focus on how to improve the cure rate for adult leukemia by incorporating new drugs and developing new treatment strategies.
日本成人白血病研究组（JALSG）成立于1987年，是日本首个大型多中心成人白血病研究组。它已发展成为一个由66个机构组成的国际认可的全国性组织。在两年的研究期内，急性髓系白血病（AML）的每个方案都招募了300多个新病例，从而能够开展随机研究。JALSG的研究成果已发表在国际期刊上，为日本循证医学做出了很大贡献。出于管理目的，已成功采用互联网系统进行病例录入和数据管理。政府为癌症研究提供的资金已提供给JALSG的首席医生，极大地增强了其研究活动。JALSG未来的研究将集中于如何通过纳入新药和制定新的治疗策略来提高成人白血病的治愈率。
